Summary: In adults with Stage II, Grade B periodontitis and type 2 diabetes mellitus, adjunctive local application of hyaluronan-minocycline gel combined with subgingival instrumentation (scaling and root planing) demonstrated significantly enhanced clinical periodontal parameters including pocket depth reduction and clinical attachment gain compared to subgingival instrumentation alone or gel monotherapy without mechanical debridement, with transient microbiological improvements and no major adverse effects. PICO Description Population Adults diagnosed with Stage II, Grade B periodontitis and type 2 diabetes mellitus, representing moderate periodontitis with diabetes as a grade-modifying factor. Intervention Adjunctive local application of hyaluronan-minocycline gel combined with subgingival instrumentation (scaling and…
Author: FWA
Summary: In young children with Type 1 diabetes mellitus treated with multiple daily insulin injections (MDI), bedtime snacking prior to the nocturnal period demonstrated significantly impaired nocturnal glycemic control with reduced time in range (TIR) compared to no bedtime snack (going to sleep without additional food intake after dinner), with no reduction in hypoglycemia frequency, negating its primary intended benefit. PICO Description Population Young children diagnosed with Type 1 diabetes mellitus treated with multiple daily insulin injections (MDI), representing the population most commonly given bedtime snacks due to parental hypoglycemia concerns. Intervention Bedtime snacking prior to the nocturnal period, following…
Clinical Context Childhood obesity has reached epidemic proportions globally, with the World Health Organization reporting that over 340 million children and adolescents aged 5-19 were overweight or obese in 2016. The metabolic consequences of pediatric obesity extend far beyond aesthetics: insulin resistance, dyslipidemia, fatty liver disease, and early atherosclerosis can develop during adolescence, setting the stage for premature cardiovascular disease and type 2 diabetes in young adulthood. School-based interventions represent a promising strategy for addressing pediatric obesity at scale. Children spend approximately 6-8 hours daily in school environments, making this setting ideal for structured physical activity programs. However, many traditional…
Clinical Context Diabetic peripheral neuropathy (DPN) affects approximately 50% of patients with diabetes during their lifetime and is the leading cause of non-traumatic lower limb amputations. The condition manifests as numbness, tingling, burning pain, and loss of protective sensation in a “stocking-glove” distribution, progressively impacting quality of life and increasing fall risk. Despite its prevalence, treatment options for DPN remain limited, with current therapies focusing on symptomatic relief (gabapentin, pregabalin, duloxetine) rather than disease modification. Glycemic control is the only established intervention that can prevent or slow DPN progression, yet even with intensive glucose management, many patients develop neuropathy. This…
Summary: In patients with type 2 diabetes mellitus accompanied by cognitive decline, Huayu Tongluo moxibustion therapy targeting specific acupuncture points demonstrated significant improvements in cognitive function scores and reduced insulin resistance indices compared to standard care or placebo treatment without moxibustion, with good tolerability with only minor adverse events such as mild skin irritation at treatment sites. PICO Description Population Patients diagnosed with type 2 diabetes mellitus accompanied by cognitive decline. Intervention Huayu Tongluo moxibustion therapy administered according to standardized treatment protocols, targeting specific acupuncture points believed to influence cognitive function and metabolic health. Comparison Standard care or placebo treatment…
Summary: In patients with diabetes or prediabetes identified through electronic health records (EHR) recruitment, invitation and recruitment into a physical activity behavioral trial demonstrated lower participation rates among males, Hispanics, and Spanish speakers compared to females, non-Hispanics, and English speakers compared to differences across demographic groups including sex, ethnicity, and language, with no significant differences related to neighborhood deprivation levels. PICO Description Population Patients with diabetes or prediabetes identified through electronic health records (EHR) recruitment. Intervention Invitation and recruitment into a physical activity behavioral trial targeting patients with diabetes or prediabetes. Comparison Differences in recruitment participation rates across demographic groups…
Summary: In patients with diabetes receiving care in primary healthcare institutions, personalized patient education using the CAPDCA (collection-assessment-plan-do-check-aggrandizement) iterative model demonstrated significantly enhanced glycemic control, improved medication adherence, and better quality of life measures compared to standard or usual care without structured personalized education programs, with no significant adverse effects and scalability for widespread implementation. PICO Description Population Patients diagnosed with diabetes receiving care in primary healthcare institutions. Intervention Personalized patient education using the collection-assessment-plan-do-check-aggrandizement (CAPDCA) iterative model that tailors educational content to individual patient needs, preferences, and circumstances. Comparison Standard or usual care without structured personalized education programs. Outcome…
Summary: In adults with overweight or obesity who received oral vancomycin for seven days, oral supplementation with 2′-fucosyllactose (2′-FL) for eight weeks following vancomycin treatment demonstrated significantly enhanced gut microbial resilience at two weeks and reduced fasting plasma IL-6 concentrations at eight weeks compared to placebo supplementation for eight weeks following the same vancomycin course, with no sustained differences in microbial composition or metabolic markers at end of intervention. PICO Description Population Adults with overweight or obesity who received oral vancomycin for seven days. Intervention Oral supplementation with 2′-fucosyllactose (2′-FL), a human milk oligosaccharide, for eight weeks following vancomycin treatment.…
Clinical Context The treatment of type 2 diabetes increasingly involves both pharmacological agents and dietary interventions, yet the optimal combination of these approaches remains an active area of investigation. GLP-1 receptor agonists like dulaglutide have become cornerstone therapies for type 2 diabetes, providing HbA1c reductions of 1.0-1.5% along with meaningful weight loss. Simultaneously, low-carbohydrate and ketogenic diets have gained attention for their ability to reduce glucose variability, lower insulin requirements, and promote weight loss through carbohydrate restriction. The ketogenic diet—typically defined as carbohydrate intake below 50g daily (or 5-10% of calories)—induces a metabolic shift toward fat oxidation and ketone body…
Summary: In patients with type 2 diabetes mellitus having baseline HbA1c less than 7.5% (well-controlled diabetes), administration of AntiAGE-Biom probiotic targeting advanced glycation end product pathways demonstrated significant improvements in metabolic control and body composition metrics compared to placebo or standard care without probiotic supplementation, with no significant adverse events reported. PICO Description Population Patients with type 2 diabetes mellitus having baseline HbA1c less than 7.5% (well-controlled diabetes). Intervention Administration of AntiAGE-Biom probiotic, a formulation designed to target advanced glycation end product (AGE) pathways through specific bacterial strains. Comparison Placebo or standard care without probiotic supplementation. Outcome Significant improvements in…